Examine.com vs AgingResearch.News

Choose Examine.com for

Health-conscious people and health professionals who want supplement research summarized and reviewed by credentialed people, with dosage, ratings and practical guides.

Choose AgingResearch.News for

People who want each new aging study as it appears, supplements and peptides among them, with its design and size in words, and a free page for each supplement showing where its research stands.

Side by side

What	AgingResearch.News	Examine.com
What it is	A reader of aging research: feeds, stories, evidence pages and Ask	Expert-reviewed summaries of supplement and nutrition research¹
Written by	An AI writer, checked against the paper by a second model. No human editor reads each story.	A team of PhDs, MDs, RDs and PharmDs with “zero industry ties”, it says¹
Coverage	Aging research only: biology, clinical work, AI and data, and the field's trials, grants, companies and news.	950+ supplements, 1,000+ health outcomes, 100,000+ studies reviewed¹
New research	New papers from PubMed, bioRxiv and medRxiv every 10 minutes; arXiv, other preprint servers and the journals PubMed misses within hours; papers in other languages translated, then judged.	100+ new study summaries a month; a Research Feed by email, daily, weekly or monthly¹
How evidence is shown	Each card names the study in words (“Randomized trial in 410 people”). Each drug, supplement, gene and process has a page: the species its findings reached, whether independent labs found the same, findings that point the other way, trials with no results posted, funders and company ties. No ratings.	Ratings from A to F for each supplement and outcome, with effect sizes, study counts and dosage¹
Practical guides	None: it reports what studies found and gives no advice	Dosage, form and timing; a Healthy Aging guide by 5 researchers; a Clinician Edition with a drug-supplement safety checker¹
Answers	Ask AgingResearch.News answers from the papers it has read, every claim cited, animal and cell results kept apart from human ones: 3 questions a day free, 20 with Plus.	ExamineAI, which answers from Examine's own published material¹
Price	Free to read. Plus $12 a month or $99 a year; Pro, for company and pipeline intelligence, $59 a month.	Examine+ $29 a month or $198 a year; $999 once for life; Clinician Edition from $49 a month¹

What it is: AgingResearch.News A reader of aging research: feeds, stories, evidence pages and Ask; Examine.com Expert-reviewed summaries of supplement and nutrition research¹
Written by: AgingResearch.News An AI writer, checked against the paper by a second model. No human editor reads each story.; Examine.com A team of PhDs, MDs, RDs and PharmDs with “zero industry ties”, it says¹
Coverage: AgingResearch.News Aging research only: biology, clinical work, AI and data, and the field's trials, grants, companies and news.; Examine.com 950+ supplements, 1,000+ health outcomes, 100,000+ studies reviewed¹
New research: AgingResearch.News New papers from PubMed, bioRxiv and medRxiv every 10 minutes; arXiv, other preprint servers and the journals PubMed misses within hours; papers in other languages translated, then judged.; Examine.com 100+ new study summaries a month; a Research Feed by email, daily, weekly or monthly¹
How evidence is shown: AgingResearch.News Each card names the study in words (“Randomized trial in 410 people”). Each drug, supplement, gene and process has a page: the species its findings reached, whether independent labs found the same, findings that point the other way, trials with no results posted, funders and company ties. No ratings.; Examine.com Ratings from A to F for each supplement and outcome, with effect sizes, study counts and dosage¹
Practical guides: AgingResearch.News None: it reports what studies found and gives no advice; Examine.com Dosage, form and timing; a Healthy Aging guide by 5 researchers; a Clinician Edition with a drug-supplement safety checker¹
Answers: AgingResearch.News Ask AgingResearch.News answers from the papers it has read, every claim cited, animal and cell results kept apart from human ones: 3 questions a day free, 20 with Plus.; Examine.com ExamineAI, which answers from Examine's own published material¹
Price: AgingResearch.News Free to read. Plus $12 a month or $99 a year; Pro, for company and pipeline intelligence, $59 a month.; Examine.com Examine+ $29 a month or $198 a year; $999 once for life; Clinician Edition from $49 a month¹

Where Examine.com is stronger

Its summaries are written and reviewed by credentialed people; AgingResearch.News's stories are written by an AI writer and checked by a second model.
It gives dosage, form and timing and ranks supplements for a goal; AgingResearch.News reports what studies found and gives no advice.
It sums up each supplement and outcome in a rating from A to F; AgingResearch.News shows how the evidence is built and leaves the weighing to you.
Its Clinician Edition adds a drug-supplement safety checker, a protocol builder and patient handouts.
It has been reader-supported since 2011, with no ads, sponsorships or supplement sales, it says.

Where AgingResearch.News is different

It reads every new paper as it appears, so new research on a supplement or peptide is judged the day it is published, and what bears on aging reaches the feeds.
Supplements sit beside drugs, genes and processes in one record, so a supplement's page shows its trials, its studies in people, animals and cells, and who paid for them.
Peptides have a page of their own, and published longevity protocols are set out part by part with the research on each.
Reading is free, each supplement's page included; a free account adds Ask, follows and the Monday digest.
It works inside ChatGPT and Claude and has a data API.

On AgingResearch.News now

On a typical day this past week, 4,300 new papers were read and 56 stories published, from a record of 707,854 papers.

Blood test model may reduce Alzheimer’s brain-scan use
Study in people · Oct 20, 2026
Cancer-promoting signals and immunity shape cell clearance in mice
Experiments in animals · Oct 20, 2026
Face-photo predictions linked to mortality in cancer patients
Study in people · Oct 20, 2026

Supplements
Each supplement taken for longevity, with its whole research record
Peptides
Peptides people take, approved as medicines or not, with their research
Protocols
Published longevity protocols, part by part, with the research on each
Creatine
A supplement's page: its studies in people, animals and cells
NMN
What the research on NMN found, in people and in animals
Ask AgingResearch.News
Questions answered from the papers, every claim cited

Read today's research Ask a question

Sources

Every fact about Examine.com above is from its own pages, read on the date given.

1. Examine+, read Oct 20, 2026